The author of a citizen petition recommending changing or removing weight-based instructions for children’s doses of single-ingredient, liquid OTC acetaminophen available in the US also proposes a solution to the problem the petition details, his patented device.
The petition Michael Creaturo, managing director of Sarasota, FL, firm Parenteral Technologies LLC, submitted to the Food and Drug Administration in April isn’t the first suggestion to the agency...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?